| OA15.03 | Novel trimer-only (TO) producing HIV-1 envelope glycoprotein constructs for inducing broadly neutralizing antibody responses by genetic vaccination | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA15.04 | Structural basis of neutralizing antibodies targeting the CD4-binding site and fusion peptide elicited by immunization with heterologous HIV-1 Env in NHP | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA15.05LB | Cross-reactivity between HIV-1 bnAbs and parasite glycans | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA18.05LB | Multivalent antigen presentation increases the antibody binding breadth and neutralizing potency upon the immunization with a self-assembling HIV env vaccine | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA22.02 | Dynamics of mucosal immune responses elicited by systemic prime/boost vaccination | Oral Abstract Session | Novel vaccine and other prevention approaches |
| PE21.01 | gp120-mediated CD4+ T cell activation is inhibited by non-neutralizing V2 loop antibodies | E-poster | Novel vaccine and other prevention approaches |
| PE21.02 | CD40-targeted vaccine increases magnitude of HIV-Env specific responses | E-poster | Novel vaccine and other prevention approaches |
| PE21.04LB | Advances in the use of a bacterially derived glycoside for inducing oligomannose-targeted neutralizing antibodies to HIV-1 | E-poster | Novel vaccine and other prevention approaches |
| PE21.05LB | Immunization with HIV-1 fusion peptide carrier conjugate in a cocktail with HIV-envelope trimer elicits potent and cross-clade neutralization activity in guinea pigs | E-poster | Novel vaccine and other prevention approaches |
| PE21.07LB | HIV-1 fusion peptide (FP) conjugate and envelope trimer cocktail immunization elicit diverse FP-directed neutralizing antibodies in non-human primates | E-poster | Novel vaccine and other prevention approaches |